_id
695fba6bc2e91020a7bd4322
Ticker
0JQ2.LSE
Name
KALA BIO, Inc.
Exchange
LSE
Address
1167 Massachusetts Avenue, Arlington, MA, United States, 02476
Country
UK
Sector
Industry
Currency
USD
Website
https://www.kalarx.com
Description
KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases. The company's lead product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; and limbal stem cell deficiency and other rare corneal diseases. Its preclinical development product consists of KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.
Last Close
0.6618
Volume
24788
Current Price
0.65
Change
0.0228
Last Updated
2026-01-08T14:08:43.525Z
Ipo Date
-
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
7239000
Operating Income
-7239000
Interest Expense
963000
Pretax Income
-7564000
Net Income
-7564000
Eps
-1.0740569661980186
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-6473000
Operating Margin
-
Total Other Income Expense Net
-325000
Cash
21096000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
24274000
Property Plant Equipment
603000
Total Assets
25021000
Payables
917000
Short Term Debt
28831000
Long Term Debt
-
Total Liabilities
1112000
Equity
-8665000
Bs_currency_symbol
-
Depreciation
128000
Change In Working Capital
1858000
Cash From Operations
-10877000
Capital Expenditures
16000
Cash From Investing
1000
Cash From Financing
30000
Net Change In Cash
-10846000
Cf_currency_symbol
-
PE
-
PB
-0.5282858684362377
ROE
87.2937103289094
ROA
-30.2306062907158
FCF
-10893000
Fcf Percent
-
Piotroski FScore
0
Health Score
38
Deep Value Investing Score
0
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
2
Net Net Investing Score
0
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
7239000
Quarters > 0 > income Statement > operating Income
-7239000
Quarters > 0 > income Statement > interest Expense
963000
Quarters > 0 > income Statement > pretax Income
-7564000
Quarters > 0 > income Statement > net Income
-7564000
Quarters > 0 > income Statement > eps
-1.0740569661980186
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
7042457
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-6473000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-325000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
21096000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
24274000
Quarters > 0 > balance Sheet > property Plant Equipment
603000
Quarters > 0 > balance Sheet > total Assets
25021000
Quarters > 0 > balance Sheet > payables
917000
Quarters > 0 > balance Sheet > short Term Debt
28831000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1112000
Quarters > 0 > balance Sheet > equity
-8665000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-7564000
Quarters > 0 > cash Flow > depreciation
128000
Quarters > 0 > cash Flow > change In Working Capital
1858000
Quarters > 0 > cash Flow > cash From Operations
-10877000
Quarters > 0 > cash Flow > capital Expenditures
16000
Quarters > 0 > cash Flow > cash From Investing
1000
Quarters > 0 > cash Flow > cash From Financing
30000
Quarters > 0 > cash Flow > net Change In Cash
-10846000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-1.0740569661980186
Quarters > 0 > ratios > PB
-0.5282858684362377
Quarters > 0 > ratios > ROE
87.2937103289094
Quarters > 0 > ratios > ROA
-30.2306062907158
Quarters > 0 > ratios > FCF
-10893000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
67000
Quarters > 1 > income Statement > gross Profit
-67000
Quarters > 1 > income Statement > operating Expenses
11028000
Quarters > 1 > income Statement > operating Income
-10875000
Quarters > 1 > income Statement > interest Expense
1081000
Quarters > 1 > income Statement > pretax Income
-11155000
Quarters > 1 > income Statement > net Income
-11155000
Quarters > 1 > income Statement > eps
-1.7126999890067844
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
6513108
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-10007000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-127000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
31942000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
127000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
33663000
Quarters > 1 > balance Sheet > property Plant Equipment
2164000
Quarters > 1 > balance Sheet > total Assets
36053000
Quarters > 1 > balance Sheet > payables
658000
Quarters > 1 > balance Sheet > short Term Debt
10323000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
39259000
Quarters > 1 > balance Sheet > equity
-3206000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-11155000
Quarters > 1 > cash Flow > depreciation
67000
Quarters > 1 > cash Flow > change In Working Capital
694000
Quarters > 1 > cash Flow > cash From Operations
-7734000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-16000
Quarters > 1 > cash Flow > cash From Financing
-2530000
Quarters > 1 > cash Flow > net Change In Cash
-10280000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.7126999890067844
Quarters > 1 > ratios > PB
-1.3204991266375545
Quarters > 1 > ratios > ROE
347.94135995009356
Quarters > 1 > ratios > ROA
-30.940559731506394
Quarters > 1 > ratios > FCF
-7734000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-68000
Quarters > 2 > income Statement > operating Expenses
10648000
Quarters > 2 > income Statement > operating Income
-10669000
Quarters > 2 > income Statement > interest Expense
1091000
Quarters > 2 > income Statement > pretax Income
-8947000
Quarters > 2 > income Statement > net Income
-8947000
Quarters > 2 > income Statement > eps
-1.4098935858902855
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
6345869
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-7788000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1722000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
42222000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
2471000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
45717000
Quarters > 2 > balance Sheet > property Plant Equipment
2296000
Quarters > 2 > balance Sheet > total Assets
48252000
Quarters > 2 > balance Sheet > payables
931000
Quarters > 2 > balance Sheet > short Term Debt
15896000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
42544000
Quarters > 2 > balance Sheet > equity
5708000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-8947000
Quarters > 2 > cash Flow > depreciation
68000
Quarters > 2 > cash Flow > change In Working Capital
-2552000
Quarters > 2 > cash Flow > cash From Operations
-8824000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-135000
Quarters > 2 > cash Flow > net Change In Cash
-8959000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-1.4098935858902855
Quarters > 2 > ratios > PB
0.7226375
Quarters > 2 > ratios > ROE
-156.7449194113525
Quarters > 2 > ratios > ROA
-18.54223659122938
Quarters > 2 > ratios > FCF
-8824000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
24
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
254000
Quarters > 3 > income Statement > cost Of Revenue
69000
Quarters > 3 > income Statement > gross Profit
127000
Quarters > 3 > income Statement > operating Expenses
9390000
Quarters > 3 > income Statement > operating Income
-9459000
Quarters > 3 > income Statement > interest Expense
1392000
Quarters > 3 > income Statement > pretax Income
-8175000
Quarters > 3 > income Statement > net Income
-8175000
Quarters > 3 > income Statement > eps
-1.7413583361858949
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
4694611
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-6714000
Quarters > 3 > income Statement > operating Margin
-3724.0157480314965
Quarters > 3 > income Statement > total Other Income Expense Net
1284000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
51181000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
52797000
Quarters > 3 > balance Sheet > property Plant Equipment
2440000
Quarters > 3 > balance Sheet > total Assets
55483000
Quarters > 3 > balance Sheet > payables
628000
Quarters > 3 > balance Sheet > short Term Debt
10716000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
43151000
Quarters > 3 > balance Sheet > equity
12332000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-8175000
Quarters > 3 > cash Flow > depreciation
69000
Quarters > 3 > cash Flow > change In Working Capital
1028000
Quarters > 3 > cash Flow > cash From Operations
-4598000
Quarters > 3 > cash Flow > capital Expenditures
69000
Quarters > 3 > cash Flow > cash From Investing
-69000
Quarters > 3 > cash Flow > cash From Financing
6646000
Quarters > 3 > cash Flow > net Change In Cash
1979000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1.7413583361858949
Quarters > 3 > ratios > PB
0.24744543869607527
Quarters > 3 > ratios > ROE
-66.2909503730133
Quarters > 3 > ratios > ROA
-14.73424292125516
Quarters > 3 > ratios > FCF
-4667000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-18.374015748031496
Quarters > 3 > health Score
16
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
259000
Annuals > 0 > income Statement > gross Profit
-259000
Annuals > 0 > income Statement > operating Expenses
40175000
Annuals > 0 > income Statement > operating Income
-40983000
Annuals > 0 > income Statement > interest Expense
5783000
Annuals > 0 > income Statement > pretax Income
-38511000
Annuals > 0 > income Statement > net Income
-38511000
Annuals > 0 > income Statement > eps
-6.976327116212339
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
5520240
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-40983000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
2472000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
51181000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
52797000
Annuals > 0 > balance Sheet > property Plant Equipment
2440000
Annuals > 0 > balance Sheet > total Assets
55483000
Annuals > 0 > balance Sheet > payables
628000
Annuals > 0 > balance Sheet > short Term Debt
10716000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
43151000
Annuals > 0 > balance Sheet > equity
12332000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-38511000
Annuals > 0 > cash Flow > depreciation
259000
Annuals > 0 > cash Flow > change In Working Capital
-1779000
Annuals > 0 > cash Flow > cash From Operations
-29382000
Annuals > 0 > cash Flow > capital Expenditures
208000
Annuals > 0 > cash Flow > cash From Investing
-208000
Annuals > 0 > cash Flow > cash From Financing
29876000
Annuals > 0 > cash Flow > net Change In Cash
286000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-6.976327116212339
Annuals > 0 > ratios > PB
0.2909630230295167
Annuals > 0 > ratios > ROE
-312.2851119039896
Annuals > 0 > ratios > ROA
-69.41045004776237
Annuals > 0 > ratios > FCF
-29590000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
23
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
-
Annuals > 1 > income Statement > cost Of Revenue
303000
Annuals > 1 > income Statement > gross Profit
-303000
Annuals > 1 > income Statement > operating Expenses
38850000
Annuals > 1 > income Statement > operating Income
-39153000
Annuals > 1 > income Statement > interest Expense
5814000
Annuals > 1 > income Statement > pretax Income
-42199000
Annuals > 1 > income Statement > net Income
-42199000
Annuals > 1 > income Statement > eps
-17.35150542267953
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
2432008
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-36082000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-3046000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
50895000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
236000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
52870000
Annuals > 1 > balance Sheet > property Plant Equipment
2778000
Annuals > 1 > balance Sheet > total Assets
55949000
Annuals > 1 > balance Sheet > payables
919000
Annuals > 1 > balance Sheet > short Term Debt
668000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
48445000
Annuals > 1 > balance Sheet > equity
7504000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-42199000
Annuals > 1 > cash Flow > depreciation
303000
Annuals > 1 > cash Flow > change In Working Capital
8895000
Annuals > 1 > cash Flow > cash From Operations
-27927000
Annuals > 1 > cash Flow > capital Expenditures
610000
Annuals > 1 > cash Flow > cash From Investing
-429000
Annuals > 1 > cash Flow > cash From Financing
8506000
Annuals > 1 > cash Flow > net Change In Cash
-19850000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-17.35150542267953
Annuals > 1 > ratios > PB
0.21066167377398723
Annuals > 1 > ratios > ROE
-562.3534115138593
Annuals > 1 > ratios > ROA
-75.42404689985523
Annuals > 1 > ratios > FCF
-28537000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
23
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
3892000
Annuals > 2 > income Statement > cost Of Revenue
2560000
Annuals > 2 > income Statement > gross Profit
1332000
Annuals > 2 > income Statement > operating Expenses
82688000
Annuals > 2 > income Statement > operating Income
-81356000
Annuals > 2 > income Statement > interest Expense
7266000
Annuals > 2 > income Statement > pretax Income
-44822000
Annuals > 2 > income Statement > net Income
-44822000
Annuals > 2 > income Statement > eps
-29.476309194133147
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1520611
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-36696000
Annuals > 2 > income Statement > operating Margin
-2090.339157245632
Annuals > 2 > income Statement > total Other Income Expense Net
36534000
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
70495000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
6497000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
85942000
Annuals > 2 > balance Sheet > property Plant Equipment
416000
Annuals > 2 > balance Sheet > total Assets
86820000
Annuals > 2 > balance Sheet > payables
2349000
Annuals > 2 > balance Sheet > short Term Debt
5013000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
67846000
Annuals > 2 > balance Sheet > equity
18974000
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-44822000
Annuals > 2 > cash Flow > depreciation
537000
Annuals > 2 > cash Flow > change In Working Capital
491000
Annuals > 2 > cash Flow > cash From Operations
-78908000
Annuals > 2 > cash Flow > capital Expenditures
313000
Annuals > 2 > cash Flow > cash From Investing
62717000
Annuals > 2 > cash Flow > cash From Financing
-7942000
Annuals > 2 > cash Flow > net Change In Cash
-24133000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-29.476309194133147
Annuals > 2 > ratios > PB
0.05209218667650469
Annuals > 2 > ratios > ROE
-236.22852324233162
Annuals > 2 > ratios > ROA
-51.62635337479843
Annuals > 2 > ratios > FCF
-79221000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-20.354830421377184
Annuals > 2 > health Score
16
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
11240000
Annuals > 3 > income Statement > cost Of Revenue
4097000
Annuals > 3 > income Statement > gross Profit
7143000
Annuals > 3 > income Statement > operating Expenses
116576000
Annuals > 3 > income Statement > operating Income
-109433000
Annuals > 3 > income Statement > interest Expense
8380000
Annuals > 3 > income Statement > pretax Income
-142605000
Annuals > 3 > income Statement > net Income
-142605000
Annuals > 3 > income Statement > eps
-109.3549663511383
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1304056
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-131957000
Annuals > 3 > income Statement > operating Margin
-973.6032028469751
Annuals > 3 > income Statement > total Other Income Expense Net
-33172000
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
92136000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
17455000
Annuals > 3 > balance Sheet > inventories
8639000
Annuals > 3 > balance Sheet > total Current Assets
124366000
Annuals > 3 > balance Sheet > property Plant Equipment
4021000
Annuals > 3 > balance Sheet > total Assets
139427000
Annuals > 3 > balance Sheet > payables
2779000
Annuals > 3 > balance Sheet > short Term Debt
1422000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
122623000
Annuals > 3 > balance Sheet > equity
16804000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-142605000
Annuals > 3 > cash Flow > depreciation
975000
Annuals > 3 > cash Flow > change In Working Capital
-10616000
Annuals > 3 > cash Flow > cash From Operations
-108235000
Annuals > 3 > cash Flow > capital Expenditures
886000
Annuals > 3 > cash Flow > cash From Investing
70803000
Annuals > 3 > cash Flow > cash From Financing
42554000
Annuals > 3 > cash Flow > net Change In Cash
5122000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-109.3549663511383
Annuals > 3 > ratios > PB
0.05044253749107355
Annuals > 3 > ratios > ROE
-848.6372292311355
Annuals > 3 > ratios > ROA
-102.27932896784696
Annuals > 3 > ratios > FCF
-109121000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-9.708274021352313
Annuals > 3 > health Score
15
Valuation > metrics > PE
-1.0740569661980186
Valuation > metrics > PB
-0.5282858684362377
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
87.2937103289094
Profitability > metrics > ROA
-31.160912910933508
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-7.517133956386293
Risk > final Score
0
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.8159876294204652
Liquidity > metrics > Quick Ratio
0.8159876294204652
Liquidity > final Score
51
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
55
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-10
Prev Risks > 1
-33
Prev Risks > 2
-21
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:13:50.552Z
KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases. The company's lead product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; and limbal stem cell deficiency and other rare corneal diseases. Its preclinical development product consists of KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of KALA BIO, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.